STOCK TITAN

If You Invested in Astrana Health (ASTH)

Services-management Consulting Services · Medical Care Facilities · NASDAQ
$1,000 invested 1 Year Ago
$855
-14.5% total -14.7% CAGR
Bought on Apr 7, 2025 at $29.29
$1,000 invested 5 Years Ago
$913
-8.7% total -1.8% CAGR
Bought on Apr 6, 2021 at $27.43

Custom Calculation

Choose your own date and amount for ASTH

$1,000 Investment Over Time

ASTH vs S&P 500

Year-by-Year Returns

ASTH annual performance
Year Start Price End Price Annual Return Cumulative
2017 $7.50 $24.00 +220.0% +220.0%
2018 $24.00 $19.85 -17.3% +164.7%
2019 $19.56 $18.41 -5.9% +145.5%
2020 $18.22 $18.27 +0.3% +143.6%
2021 $19.25 $73.48 +281.7% +879.7%
2022 $67.04 $29.59 -55.9% +294.5%
2023 $28.26 $38.30 +35.5% +410.7%
2024 $38.78 $31.53 -18.7% +320.4%
2025 $32.20 $24.81 -23.0% +230.8%
2026 $25.22 $25.05 -0.7% +234.0%

About Astrana Health

Services-management Consulting Services · NASDAQ

Astrana Health, Inc. (NASDAQ: ASTH) is described as a physician-centric, AI-powered and technology-enabled healthcare company that supports providers in delivering high-quality, patient-centered care. According to the company’s public statements, Astrana is focused on making care more accessible, coordinated, and high-value by combining a scalable care delivery infrastructure, a proprietary technology platform, and aligned provider networks.

Astrana operates in the healthcare sector and is associated with the medical care facilities and population health management space. The company characterizes itself as patient-centered and physician-centric, with an emphasis on proactive, preventive care delivered at scale. Its model is built from the physician’s perspective, aiming to improve patient outcomes, enhance patient experiences, support provider well-being, and create greater value across the healthcare system.

Business model and segments

Based on available information, Astrana is an integrated population health management company. It focuses on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company reports three segments: Care Partners, Care Delivery, and Care Enablement. Astrana has stated that it generates the majority of its revenue from the Care Partners segment.

Through its affiliated provider networks, management services organization, and integrated care delivery clinics that span primary, specialty, and ancillary care, Astrana supports value-based care arrangements. Public disclosures note that Astrana supports more than 20,000 providers and over 1.6 million patients in value-based care arrangements. Earlier company descriptions referenced support for more than 12,000 providers and over one million patients, indicating that Astrana has expanded the scale of its operations over time.

Technology platform and AI focus

Astrana describes its platform as both technology-enabled and AI-powered. The company highlights a proprietary, end-to-end technology platform that is designed to empower providers to deliver more proactive and preventive care. Astrana associates this platform with real-time visibility into patients’ health, longitudinal patient relationships, and value-based care operations. In its public communications, Astrana links its use of automation and AI to operational efficiency and to supporting clinical and care management capabilities.

Value-based care and population health

The company emphasizes value-based care arrangements as a core part of its business. Astrana states that it supports providers and patients in value-based arrangements across multiple lines of business, including Medicare Advantage, Medicaid, and Commercial products, particularly through its networks and acquired businesses. Its population health management approach is described as coordinated and outcomes-based, with a focus on controlling medical cost trends while maintaining or improving quality and outcomes.

According to company materials, Astrana’s affiliated networks and clinics span primary care, specialty care, and ancillary services. Within this framework, Astrana’s Care Partners, Care Delivery, and Care Enablement segments relate to provider networks, care delivery sites, and enabling services and technology that support value-based care and delegated risk models.

Prospect Health acquisition and expanded footprint

On July 1, 2025, Astrana completed the acquisition of Prospect Health, a value-based integrated care delivery network. Prospect Health has been described as coordinating the delivery of high-quality care through a network of over 11,000 providers across Southern California, Texas, Arizona, and Rhode Island in its medical groups. Prospect Health serves approximately 600,000 members across Medicare Advantage, Medicaid, and Commercial lines of business and operates a California Restricted Knox-Keene-licensed health plan, a management services organization, a specialty pharmacy, and an acute care hospital.

Astrana has stated that the acquisition of Prospect Health is intended to deepen its capabilities in providing access to high-quality and high-value care and to expand its scale, capabilities, and physician reach across key markets. Subsequent company communications refer to combined operations with Prospect Health and integration efforts that are intended to expand Astrana’s care delivery platform.

Provider networks and care delivery infrastructure

Across its operations, Astrana reports that it supports providers through affiliated provider networks and a management services organization. The company also references integrated care delivery clinics that cover primary, specialty, and ancillary care. These elements form a care delivery infrastructure that Astrana associates with coordinated care, value-based arrangements, and delegated models where it manages aspects of medical cost and care quality.

In addition to its own networks and clinics, Astrana has highlighted partnerships with other health systems and provider groups. For example, the company has publicly announced a strategic partnership with Intermountain Health to expand access to coordinated care in southern Nevada by integrating Astrana’s provider network and clinics with Intermountain’s health system capabilities. Astrana has also disclosed partnerships with provider groups in Southern California within its Care Enablement business.

Financial reporting and growth orientation

Astrana is a public company that files reports with the U.S. Securities and Exchange Commission and trades on NASDAQ under the symbol ASTH. The company issues quarterly earnings releases and related Form 8-K filings that describe its financial results, segment performance, and guidance. In these communications, Astrana frequently references revenue and adjusted EBITDA, as well as medical cost trends and performance across its Care Partners, Care Delivery, and Care Enablement segments.

Company statements link its financial performance to the scale of its provider and patient base, the effectiveness of its value-based care model, and integration of acquired entities such as Collaborative Health Systems and Prospect Health. Astrana also notes the use of a term loan credit facility in connection with the Prospect Health acquisition and has discussed net leverage targets in its public disclosures.

Corporate communications and investor engagement

Astrana regularly participates in healthcare and investor conferences, including events hosted by J.P. Morgan, Wells Fargo, Morgan Stanley, Baird, and William Blair. The company uses these events, along with conference calls and webcasts, to discuss its financial results, strategy, and operations. Astrana also furnishes investor presentations via Form 8-K and maintains an investor relations calendar where it posts webcast links and presentation materials.

FAQs about Astrana Health, Inc.

  • What does Astrana Health, Inc. do?

    Astrana Health, Inc. describes itself as a physician-centric, AI-powered and technology-enabled healthcare company. It focuses on delivering high-quality, patient-centered care through value-based care arrangements, population health management, and care coordination, particularly for senior patients and patients with multiple chronic conditions.

  • How does Astrana Health generate revenue?

    According to company disclosures, Astrana operates through three reportable segments: Care Partners, Care Delivery, and Care Enablement. The company has stated that it generates the majority of its revenue from the Care Partners segment, which is associated with its provider networks and related activities.

  • What are Astrana Health’s main business segments?

    Astrana reports three segments: Care Partners, Care Delivery, and Care Enablement. These segments reflect its provider-centric networks, care delivery sites, and enabling services and technology that support value-based care and population health management.

  • How many providers and patients does Astrana support?

    In its public statements, Astrana has reported that it supports more than 20,000 providers and over 1.6 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics. Earlier disclosures referenced more than 12,000 providers and over one million patients, indicating growth over time.

  • What is the role of technology and AI at Astrana Health?

    Astrana describes its platform as proprietary, technology-enabled, and AI-powered. The company states that this platform supports proactive, preventive care, real-time visibility into patient health, and operational efficiency in value-based care and delegated models.

  • What is value-based care in the context of Astrana Health?

    In Astrana’s communications, value-based care refers to arrangements where providers are supported to deliver coordinated, outcomes-based care, often under delegated or risk-bearing models. Astrana links value-based care to managing medical cost trends while improving patient outcomes and experiences.

  • What is Prospect Health and how is it related to Astrana?

    Prospect Health is a value-based integrated care delivery network that Astrana acquired on July 1, 2025. Prospect Health has a network of over 11,000 providers across Southern California, Texas, Arizona, and Rhode Island, serves approximately 600,000 members across Medicare Advantage, Medicaid, and Commercial lines of business, and operates a health plan, a management services organization, a specialty pharmacy, and an acute care hospital. Astrana has stated that this acquisition expands its capabilities and reach.

  • On which exchange does Astrana Health trade and what is its ticker symbol?

    Astrana Health, Inc. trades on NASDAQ under the ticker symbol ASTH, as referenced in its press releases and SEC filings.

  • How does Astrana communicate with investors?

    Astrana issues press releases, hosts quarterly earnings conference calls and webcasts, files reports and current reports on Form 8-K with the SEC, and participates in healthcare and investor conferences. The company also provides investor presentations and maintains an investor relations calendar for upcoming events.

  • Is Astrana Health focused on any particular patient populations?

    Company descriptions indicate a focus on population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions, within value-based care arrangements.

Market Cap
$1.4B
Current Price
$25.05
EPS
$0.46
Revenue
$3.2B
Net Margin
0.7%
View full ASTH overview

Frequently Asked Questions

Astrana Health investment returns

How much would $1,000 invested in Astrana Health be worth today?

If you invested $1,000 in Astrana Health (ASTH) 10 years ago on 2016-04-06, your investment would be worth $3,340 today, representing a +234.0% total return, growing at a compounded rate of 12.8% per year (CAGR).

Has Astrana Health outperformed the S&P 500?

Over the past 10 years, ASTH returned +234.0% compared to +217.7% for the S&P 500, outperforming the benchmark by 16.3 percentage points.

What is Astrana Health's average annual return?

The compound annual growth rate (CAGR) of ASTH over the past 10 years is 12.8%, growing at a compounded rate each year. Individual years vary significantly — ASTH's best recent year was 2021 (+281.7%) and worst was 2022 (-55.9%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.